N-Acetyl-β-D-glucosaminidase in acute myocardial infarction

Experimental and Molecular Medicine

Volumn 35, Issue 4, 2003, Pages 275-278

  Iqbal, M Perwaiz ^a   Kazmi, Khawar A ^a   Jafri, Hasan R ^a   Mehboobali, Naseema ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

Acetylglucosaminidase; Biological markers; Inflammation; Lysosomes; Myocardial infarction

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; LYSOSOME ENZYME; N ACETYL BETA GLUCOSAMINIDASE;

ACUTE HEART INFARCTION; ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; ENZYME ACTIVITY; HEART INFARCTION SIZE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; INFLAMMATORY CELL; LYSOSOME MEMBRANE; SPECTROFLUOROMETRY; ST SEGMENT ELEVATION; STUDENT T TEST;

EID: 0141515632     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2003.37     Document Type: Article

References (15)

1. Goldberg DM. Diagnostic enzymology. In: Applied Biochemistry of Clinical Disorders (Gornell AG, ed), 1986, 34, J.P. Lippincott Company, Philadelphia
2. Inoue T, Matsunaga R, Morooka S, Uehara Y. Serum N-acetyl-beta-D-glucosaminidase activity increases in association with insulin resistance in patients with coronary artery disease. Atherosclerosis 2000;149:17-22
3. Iqbal MP, Ali AA, Waqar MA, Mehbooali N. Urinary N-acetyl-β -D-glucosominidase in rheumatoid arthritis. Exp Mol Med 1998;30:165-9
4. Iqbal MP, Ali AA, Hussain MA, Mehboobali N, Waqar MA, Javed MH, Rahbar MH. Role of N-acetyl-β-D-glucosaminidase in the diagnosis of arthopathies. Clin Chem Enzym Comms 1999;8:167-73
5. Iqbal MP, Mehboobali N, Jafri HR. N-acetyl-β-D-glucosaminidase activity in human leukemia. Med Sci Res 1999;27:35-7
6. Javed MH, Hussain AN, Shafiq M, Fayyaz KM. Plasma N-acetyl-β -D-glucosaminidase levels in chronic obstructive pulmonary diseases. Clin Chem Enzym Comms 1996;7:193-7
7. Libby PA. Atherosclerosis: The new view. Sci Amer 2002;29-37
8. Porela P, Luotolahti M, Helenius H, Pulkki K, Voipio-Pulkki L-M. Automated electrocardiographic scores to estimate myocardial injury size during the course of acute myocardial infarction. Am J Cardiol 1999;83:949-52
9. Price RG, Dance N. The demonstration of multiple heat stable forms of N-acetyl-beta-D-glucosaminidase in normal human serum. Biochem Biophys Acta 1972;271:145-53
10. Reglero A, Carretero MI, Cabezas JA. Increased serum alpha-L-fucosidase and beta-N-acetylglucosaminidase activities in diabetic, cirrhotic and gastric cancer patients. Clin Chim Acta 1980;103:155-8
11. Severini G, Aliberti LM, Girolamo MD. N-Acetyl-β-glucosaminidase isoemzymes in serum and urine of patients with diabetes mellitus. Clin Chem 1988;34:2430-2
12. Severini G, Aliberti LM, Koch M, Capurso L, Tarquini M. Clinical evaluation of serum N-acetyl-β-D-glucosaminidase as a liver function test. Biochem Med Metab Biol 1990;44:247-51
13. Severini G, Aliberti LM. Serum N-acetyl-beta-glucosaminidase activity in breast cancer. Cancer Biochem Biophys 1994;14:87-92
14. Welman E, Colbeck JF, Selwyn AP, Fox KM, Orr I. Plasma lysosomal enzyme activity in acute myocardial infarction and effects of drug. Adv Myocardiol 1980;2:359-69
15. Whiting PH, Ross IS, Borthwick L. Serum and urine N-acetyl-β -D-glucosaminidase in diabetics on diagnosis and subsequent treatment and stable insulin dependent diabetics. Clin Chim Acta 1979;92:459-63